Submission Details
| 510(k) Number | K942501 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 24, 1994 |
| Decision Date | October 06, 1994 |
| Days to Decision | 135 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K942501 is an FDA 510(k) clearance for the ACE CEDIA PHENOBARBITAL ASSAY, a Enzyme Immunoassay, Phenobarbital (Class II — Special Controls, product code DLZ), submitted by Schiapparelli Biosystems, Inc. (Columbia, US). The FDA issued a Cleared decision on October 6, 1994, 135 days after receiving the submission on May 24, 1994. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3660.
| 510(k) Number | K942501 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 24, 1994 |
| Decision Date | October 06, 1994 |
| Days to Decision | 135 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | DLZ — Enzyme Immunoassay, Phenobarbital |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3660 |